Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen Lozenge Onset of Action in Pharyngitis
NCT01986361Phase 3Completed
- Sponsor
- Reckitt
- Start
- Sep 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pharyngitis comparing Flurbiprofen Lozenge with Placebo Lozenge (2 arms). Primary endpoint: Kaplan-Meier Estimates for Time to Meaningful Pain Relief at 3 hours. Started Sep 2013; status: completed.
02
Drugs
flurbiprofen
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on NCT01986361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986361.